Guardant Health
GH
#1019
Rank
NZ$41.69 B
Marketcap
NZ$310.73
Share price
-0.48%
Change (1 day)
202.64%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

We have found no dividend yield history for this company